Viral mapping in COVID-19 deceased in the Augsburg autopsy series of the first wave: A multiorgan and multimethodological approach.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
25
04
2021
accepted:
05
07
2021
entrez:
19
7
2021
pubmed:
20
7
2021
medline:
31
7
2021
Statut:
epublish
Résumé
COVID-19 is only partly understood, and the level of evidence available in terms of pathophysiology, epidemiology, therapy, and long-term outcome remains limited. During the early phase of the pandemic, it was necessary to effectively investigate all aspects of this new disease. Autopsy can be a valuable procedure to investigate the internal organs with special techniques to obtain information on the disease, especially the distribution and type of organ involvement. During the first wave of COVID-19 in Germany, autopsies of 19 deceased patients were performed. Besides gross examination, the organs were analyzed with standard histology and polymerase-chain-reaction for SARS-CoV-2. Polymerase chain reaction positive localizations were further analyzed with immunohistochemistry and RNA-in situ hybridization for SARS-CoV-2. Eighteen of 19 patients were found to have died due to COVID-19. Clinically relevant histological changes were only observed in the lungs. Diffuse alveolar damage in considerably different degrees was noted in 18 cases. Other organs, including the central nervous system, did not show specific micromorphological alterations. In terms of SARS-CoV-2 detection, the focus remains on the upper airways and lungs. This is true for both the number of positive samples and the viral load. A highly significant inverse correlation between the stage of diffuse alveolar damage and viral load was found on a case and a sample basis. Mediastinal lymph nodes and fat were also affected by the virus at high frequencies. By contrast, other organs rarely exhibited a viral infection. Moderate to strong correlations between the methods for detecting SARS-CoV-2 were observed for the lungs and for other organs. The lung is the most affected organ in gross examination, histology and polymerase chain reaction. SARS-CoV-2 detection in other organs did not reveal relevant or specific histological changes. Moreover, we did not find CNS involvement.
Sections du résumé
BACKGROUND
COVID-19 is only partly understood, and the level of evidence available in terms of pathophysiology, epidemiology, therapy, and long-term outcome remains limited. During the early phase of the pandemic, it was necessary to effectively investigate all aspects of this new disease. Autopsy can be a valuable procedure to investigate the internal organs with special techniques to obtain information on the disease, especially the distribution and type of organ involvement.
METHODS
During the first wave of COVID-19 in Germany, autopsies of 19 deceased patients were performed. Besides gross examination, the organs were analyzed with standard histology and polymerase-chain-reaction for SARS-CoV-2. Polymerase chain reaction positive localizations were further analyzed with immunohistochemistry and RNA-in situ hybridization for SARS-CoV-2.
RESULTS
Eighteen of 19 patients were found to have died due to COVID-19. Clinically relevant histological changes were only observed in the lungs. Diffuse alveolar damage in considerably different degrees was noted in 18 cases. Other organs, including the central nervous system, did not show specific micromorphological alterations. In terms of SARS-CoV-2 detection, the focus remains on the upper airways and lungs. This is true for both the number of positive samples and the viral load. A highly significant inverse correlation between the stage of diffuse alveolar damage and viral load was found on a case and a sample basis. Mediastinal lymph nodes and fat were also affected by the virus at high frequencies. By contrast, other organs rarely exhibited a viral infection. Moderate to strong correlations between the methods for detecting SARS-CoV-2 were observed for the lungs and for other organs.
CONCLUSIONS
The lung is the most affected organ in gross examination, histology and polymerase chain reaction. SARS-CoV-2 detection in other organs did not reveal relevant or specific histological changes. Moreover, we did not find CNS involvement.
Identifiants
pubmed: 34280238
doi: 10.1371/journal.pone.0254872
pii: PONE-D-21-13695
pmc: PMC8289110
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0254872Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Front Med (Lausanne). 2021 May 14;8:656405
pubmed: 34055833
Mod Pathol. 2020 Nov;33(11):2147-2155
pubmed: 32792598
Crit Care. 2020 Aug 12;24(1):495
pubmed: 32787909
Pathobiology. 2021;88(1):88-94
pubmed: 33108789
World J Gastroenterol. 2020 Dec 28;26(48):7693-7706
pubmed: 33505145
J Med Virol. 2021 Jul;93(7):4247-4257
pubmed: 33724490
Virchows Arch. 2020 Sep;477(3):349-357
pubmed: 32607684
Front Cardiovasc Med. 2021 Jan 28;7:626975
pubmed: 33585586
Kidney Int Rep. 2020 Sep;5(9):1608-1610
pubmed: 32838080
N Engl J Med. 2020 Sep 3;383(10):989-992
pubmed: 32530583
BMJ Case Rep. 2020 Oct 31;13(10):
pubmed: 33130584
Virchows Arch. 2021 Jan;478(1):137-150
pubmed: 33604758
Rechtsmedizin (Berl). 2020;30(5):336-343
pubmed: 32836899
Ann Transl Med. 2020 Sep;8(17):1077
pubmed: 33145296
Lancet. 2020 Aug 1;396(10247):320-332
pubmed: 32682491
Lancet. 2020 Aug 29;396(10251):597-598
pubmed: 32818439
N Engl J Med. 2020 Aug 6;383(6):590-592
pubmed: 32402155
Circulation. 2021 Jan 19;143(3):230-243
pubmed: 33197204
Pathobiology. 2021;88(1):95-105
pubmed: 33161409
Arch Pathol Lab Med. 2021 Jul 1;145(7):785-796
pubmed: 33720333
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Br J Pharmacol. 2020 Oct;177(19):4375-4385
pubmed: 32698249
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Mod Pathol. 2020 Nov;33(11):2156-2168
pubmed: 32879413
Ann Intern Med. 2020 Sep 1;173(5):350-361
pubmed: 32422076
Histopathology. 2020 Aug;77(2):198-209
pubmed: 32364264
Intensive Care Med. 2021 Feb;47(2):199-207
pubmed: 33392642
medRxiv. 2021 Feb 18;:
pubmed: 33619496
BMJ. 2021 Mar 9;372:n579
pubmed: 33687922
Lancet Microbe. 2020 Oct;1(6):e245-e253
pubmed: 32844161
Neurosci Lett. 2021 Jan 18;742:135528
pubmed: 33248159
Pathologe. 2021 Mar;42(2):208-215
pubmed: 33646360
JAMA. 2020 Jun 23;323(24):2518-2520
pubmed: 32437497
Pathologe. 2021 Mar;42(2):183-187
pubmed: 33527157
Metabolism. 2021 Feb;115:154436
pubmed: 33221381
Int J Appl Basic Med Res. 2020 Oct-Dec;10(4):226-233
pubmed: 33376694
Nat Commun. 2020 Dec 9;11(1):6317
pubmed: 33298944
Pathol Res Pract. 2020 Aug;216(8):153039
pubmed: 32703502
Virchows Arch. 2021 Feb;478(2):343-353
pubmed: 32815036
Virchows Arch. 2021 Feb;478(2):301-308
pubmed: 32651729
Am J Surg Pathol. 2021 May 1;45(5):587-603
pubmed: 33481385
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):535-545
pubmed: 32408118
Zhonghua Bing Li Xue Za Zhi. 2020 Jun 8;49(6):576-582
pubmed: 32340089
Respir Res. 2021 Jan 29;22(1):32
pubmed: 33514373
Virus Res. 2006 Dec;122(1-2):119-26
pubmed: 16920216
Eur Heart J. 2020 Jun 21;41(24):2333
pubmed: 32464641
Diagnostics (Basel). 2020 Aug 09;10(8):
pubmed: 32784826
Infect Dis Poverty. 2020 Apr 28;9(1):45
pubmed: 32345362
BMC Endocr Disord. 2021 Mar 26;21(1):56
pubmed: 33771154
Nephron. 2021;145(3):275-279
pubmed: 33601392
J Am Soc Nephrol. 2020 Sep;31(9):2223-2224
pubmed: 32651224
Am J Surg Pathol. 2021 Jan;45(1):14-24
pubmed: 32826529
JAMA Intern Med. 2020 Aug 1;180(8):1045-1046
pubmed: 32407441
Front Public Health. 2021 Mar 10;9:628479
pubmed: 33777883